166 related articles for article (PubMed ID: 19162574)
1. Immune-mediated liver dysfunction after antiviral treatment in liver transplanted patients with hepatitis C: allo or autoimmune de novo hepatitis?
Merli M; Gentili F; Giusto M; Attili AF; Corradini SG; Mennini G; Rossi M; Corsi A; Bianco P
Dig Liver Dis; 2009 May; 41(5):345-9. PubMed ID: 19162574
[TBL] [Abstract][Full Text] [Related]
2. High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?
Berardi S; Lodato F; Gramenzi A; D'Errico A; Lenzi M; Bontadini A; Morelli MC; Tamè MR; Piscaglia F; Biselli M; Sama C; Mazzella G; Pinna AD; Grazi G; Bernardi M; Andreone P
Gut; 2007 Feb; 56(2):237-42. PubMed ID: 16798778
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of an escalating dose regimen of pegylated interferon alpha-2a plus ribavirin in the early phase of HCV reinfection after liver transplantation.
Zimmermann T; Böcher WO; Biesterfeld S; Zimmermann A; Kanzler S; Greif-Higer G; Barreiros AP; Sprinzl MF; Wörns MA; Lohse AW; Mönch C; Otto G; Galle PR; Schuchmann M
Transpl Int; 2007 Jul; 20(7):583-90. PubMed ID: 17433090
[TBL] [Abstract][Full Text] [Related]
4. Induction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus.
Cholongitas E; Samonakis D; Patch D; Senzolo M; Burroughs AK; Quaglia A; Dhillon A
Transplantation; 2006 Feb; 81(3):488-90. PubMed ID: 16477242
[No Abstract] [Full Text] [Related]
5. Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation.
Kontorinis N; Agarwal K; Elhajj N; Fiel MI; Schiano TD
Liver Transpl; 2006 May; 12(5):827-30. PubMed ID: 16628699
[TBL] [Abstract][Full Text] [Related]
6. Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients.
Castells L; Esteban JI; Bilbao I; Vargas V; Allende H; Ribera E; Piron M; Sauleda S; Len O; Pahissa A; Esteban R; Guardia J; Margarit C
Antivir Ther; 2006; 11(8):1061-70. PubMed ID: 17302376
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hepatitis C-virus-reinfection after liver transplant with silibinin in nonresponders to pegylated interferon-based therapy.
Eurich D; Bahra M; Berg T; Boas-Knoop S; Biermer M; Neuhaus R; Neuhaus P; Neumann U
Exp Clin Transplant; 2011 Feb; 9(1):1-6. PubMed ID: 21605016
[TBL] [Abstract][Full Text] [Related]
8. Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naïve and non-responder patients on a stable immunosuppressive regimen.
Biselli M; Andreone P; Gramenzi A; Lorenzini S; Loggi E; Bonvicini F; Cursaro C; Bernardi M
Dig Liver Dis; 2006 Jan; 38(1):27-32. PubMed ID: 16311084
[TBL] [Abstract][Full Text] [Related]
9. Cryptosporidiosis in a patient on PEG-interferon and ribavirin for recurrent hepatitis C after living donor liver transplantation.
Manz M; Steuerwald M
Transpl Infect Dis; 2007 Mar; 9(1):60-1. PubMed ID: 17313476
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of everolimus in the treatment of autoimmune hepatitis related to anti-hepatitis C virus therapy after liver transplant: three case reports.
Casanovas T; Argudo A; Peña-Cala MC
Transplant Proc; 2011; 43(6):2233-6. PubMed ID: 21839242
[TBL] [Abstract][Full Text] [Related]
11. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.
Stravitz RT; Shiffman ML; Sanyal AJ; Luketic VA; Sterling RK; Heuman DM; Ashworth A; Mills AS; Contos M; Cotterell AH; Maluf D; Posner MP; Fisher RA
Liver Transpl; 2004 Jul; 10(7):850-8. PubMed ID: 15237368
[TBL] [Abstract][Full Text] [Related]
12. Acute Graft Rejection and Formation of De Novo Donor-Specific Antibodies Triggered by Low Cyclosporine Levels and Interferon Therapy for Recurrent Hepatitis C Infection After Liver Transplantation: A Case Report.
Nakano R; Ohira M; Ishiyama K; Ide K; Kobayashi T; Tahara H; Shimizu S; Arihiro K; Imamura M; Chayama K; Tanaka Y; Ohdan H
Transplant Proc; 2017 Sep; 49(7):1634-1638. PubMed ID: 28838454
[TBL] [Abstract][Full Text] [Related]
13. New approaches to the treatment of hepatitis C virus infection after liver transplantation using ribavirin.
Bizollon T; Ducerf C; Trépo C
J Hepatol; 1995; 23 Suppl 2():22-5. PubMed ID: 8720290
[TBL] [Abstract][Full Text] [Related]
14. Anti-Golgi complex antibodies during pegylated-interferon therapy for hepatitis C.
Paraná R; Schinoni MI; de Freitas LA; Codes L; Cruz M; Andrade Z; Trepo C
Liver Int; 2006 Nov; 26(9):1148-54. PubMed ID: 17032416
[TBL] [Abstract][Full Text] [Related]
15. Peginterferon alfa-2a for hepatitis C after liver transplantation: two randomized, controlled trials.
Chalasani N; Manzarbeitia C; Ferenci P; Vogel W; Fontana RJ; Voigt M; Riely C; Martin P; Teperman L; Jiao J; Lopez-Talavera JC;
Hepatology; 2005 Feb; 41(2):289-98. PubMed ID: 15660392
[TBL] [Abstract][Full Text] [Related]
16. Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon.
Levitsky J; Fiel MI; Norvell JP; Wang E; Watt KD; Curry MP; Tewani S; McCashland TM; Hoteit MA; Shaked A; Saab S; Chi AC; Tien A; Schiano TD
Gastroenterology; 2012 May; 142(5):1132-1139.e1. PubMed ID: 22285805
[TBL] [Abstract][Full Text] [Related]
17. Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C.
Firpi RJ; Abdelmalek MF; Soldevila-Pico C; Reed A; Hemming A; Howard R; Van Der Werf W; Lauwers G; Liu C; Crawford JM; Davis GL; Nelson DR
Liver Transpl; 2002 Nov; 8(11):1000-6. PubMed ID: 12424712
[TBL] [Abstract][Full Text] [Related]
18. Pegylated interferon alpha-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C.
Ross AS; Bhan AK; Pascual M; Thiim M; Benedict Cosimi A; Chung RT
Clin Transplant; 2004 Apr; 18(2):166-73. PubMed ID: 15016131
[TBL] [Abstract][Full Text] [Related]
19. Intravenous interferon during the anhepatic phase of liver retransplantation and prevention of recurrence of cholestatic hepatitis C virus.
Kwo PY; Saxena R; Cummings OW; Tector AJ
Liver Transpl; 2007 Dec; 13(12):1710-3. PubMed ID: 18044743
[TBL] [Abstract][Full Text] [Related]
20. Controversies in the management of hepatitis C virus infection after liver transplantation.
Shiffman ML; Vargas HE; Everson GT
Liver Transpl; 2003 Nov; 9(11):1129-44. PubMed ID: 14586872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
